ArticleJournal of multidisciplinary healthcare2025
Association of Life's Essential 8 Score with All-Cause and Cardiovascular Mortality in Patients with Diabetic Nephropathy: A NHANES-Based Cohort Study.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to assess the relationship between the "Life's Essential 8" (LE8) score and all-cause and cardiovascular mortality in patients with diabetic nephropathy (DN). Methods: This observational cohort study utilized data from the National Health and Nutrition Examination Survey (NHANES, 2005-2018). A total of 1,745 patients with DN were included. The LE8 score encompassed health behaviors (diet, physical activity, nicotine control, sleep) and physiological indices (body mass index, non-high-density lipoprotein cholesterol, blood glucose, blood pressure). A multivariate Cox proportional risk model was employed to assess the effect of the LE8 score on the risk of death, and the dose-response relationship was analyzed by a restricted cubic spline (RCS) model. Subgroup analyses and multiple imputations were performed to verify the robustness of the findings. Results: After adjusting for confounders, a 10-point increase in the LE8 score was associated with a 12% reduction in the risk of all-cause mortality [hazard ratio (HR) = 0.88, P < 0.001] and a 16% reduction in the risk of cardiovascular death (HR = 0.84, P = 0.007). The risk of all-cause mortality was 33% lower in the highest tertile group compared with the lowest group (HR = 0.67, P < 0.001), and the risk of cardiovascular mortality was 36% lower (HR = 0.64, P = 0.014). RCS analysis showed that LE8 scores were linearly negatively correlated with mortality (nonlinear P > 0.05). Subgroup analyses further confirmed the consistency of this association across various characteristic subgroups. Conclusion: LE8 score has been identified as an independent protective factor for the risk of death in patients with DN, exhibiting a linear dose-response relationship consistent across sociodemographic subgroups. This finding underscores the importance of incorporating LE8 into a comprehensive assessment system for DN patients, providing a foundation for precision intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.